2022
Managing stage 4 ameloblastoma with dual BRAF/MEK inhibition: A case report with 8-year clinical follow-up.
Oral oncology
PubMed • Publisher's siteResearch at a glance
Top areas of exploration
- Fluorodeoxyglucose F18 , 14 publications
- Radiopharmaceuticals , 11 publications
- Organotechnetium Compounds , 11 publications
- Technetium , 10 publications
Research activity
My publications
Filter publications
84 publications
2020
Cancer Treatment Response to Checkpoint Inhibitors Is Associated with Cytomegalovirus Infection.
Cureus
PubMed • Publisher's site2017
Response.
Journal of the National Cancer Institute
PubMed2016
Coming full circle: an impressive case of Crohn's disease.
BMJ case reports
PubMed • Publisher's site2015
Clinical and radiographic response with combined BRAF-targeted therapy in stage 4 ameloblastoma.
Journal of the National Cancer Institute
PubMed • Publisher's site